Platelet‐rich plasma is a promising therapy for melasma

Ankita Tuknayat; Mala Bhalla; Gurvinder Pal Thami

doi:10.1111/jocd.14229

journal article Jun 03, 2021

Platelet‐rich plasma is a promising therapy for melasma

Ankita Tuknayat

Mala Bhalla Gurvinder Pal Thami

Journal of Cosmetic Dermatology Vol. 20 No. 8 pp. 2431-2436 · Wiley

View at Publisher Save 10.1111/jocd.14229

Abstract

AbstractIntroductionPlatelet‐rich plasma (PRP) is an autologous blood product which has recently been used in multiple spheres of dermatology including facial rejuvenation, androgenetic alopecia, acne scars, and wound healing. Its use in melasma is comparatively an understudied topic.Material and methodsAn extensive systematic literature search of the PubMed electronic database and Cochrane central register of controlled trials was done using the keywords “platelet rich plasma” and “melasma” in the title. Relevant studies were selected and data were analyzed by two different authors. Four articles were excluded as they did not adhere to the inclusion criteria of this review and a total of 6 articles were reviewed.The relevant references of the included articles were also traced and included.DiscussionThese studies showed that PRP has been used effectively not only as an adjuvant therapy but also as a standalone treatment for melasma. PRP contains about 30 growth factors, transforming growth factor beta (TGF‐β) being one of the growth factors having a predominant role in treatment of melasma. TGF‐β decreases signal transduction of microphthalmia‐induced transcription factor and thus decreases tyrosinase and tyrosinase‐related proteins. In addition to this, PRP also has an additional benefit of inducing collagen synthesis thus improving the quality and texture of the skin. But there is a scarcity of data and large randomized controlled trials. This review is an effort to highlight and upscale the use of this excellent blood product for melasma which is quite a treatment refractory disorder.

Topics

No keywords indexed for this article. Browse by subject →

References

34

[1]

10.1001/archderm.143.3.424

[2]

10.1046/j.1365-4362.1998.00585.x

[3]

10.1210/jcem-61-1-28

[4]

10.4103/0019-5154.84722

[5]

10.2165/00044011-199500102-00006

[6]

Ebrahimi B "Topical trenaxamic acid as a promising treatment for melasma" J Res Med Sci (2014)

[7]

Kaur A "Topical tranexamic acid with microneedling in melasma" Acta Sci Med Sci (2019)

[8]

10.1177/039139888701000111

[9]

10.1097/01.prs.0000239606.92676.cf

[10]

10.1016/j.arthro.2011.10.018

[11]

Platelet-rich plasma: evidence to support its use

Robert E Marx

Journal of Oral and Maxillofacial Surgery 10.1016/j.joms.2003.12.003

[12]

Monteiro MR "Platelet rich plasma in dermatology" Surg Cosmet Dermatol (2013)

[13]

10.1111/j.1524-4725.2012.02394.x

[14]

10.1097/dss.0000000000001965

[15]

10.1097/dss.0000000000001894

[16]

Martinez‐Zapata MJ "Autologous platelet‐rich plasma for treating chronic wounds" Cochrane Database Syst Rev (2016)

[17]

10.1111/j.1524-4725.2011.02280.x

[18]

10.1111/j.1524-4725.2011.01999.x

[19]

International Cellular Medicine Society Guidelines for PRP. Section 10 2011 Accessed fromhttp://www.cellmedicinesociety.org/attachments/370_Section%2010%20‐%20Platelet%20Rich%20Plasma%20(PRP)%20Guidelines.pdf. Last accessed on 29th May 2020.

[20]

10.1016/j.biocel.2003.10.023

[21]

10.4103/0974-2077.150734

[22]

10.1053/j.oto.2012.01.004

[23]

10.1097/dss.0000000000001049

[24]

Marlovits S "A new simplified technique for producing platelet‐rich plasma: a short technical note" Eur Spine J (2014)

[25]

10.1016/j.molcel.2008.11.002

[26]

10.1111/dsu.12348

[27]

Al‐Shami SH "Treatment of periorbital hyperpigmentation using platelet‐rich plasma injections" Am J Dermatol Venereol (2014)

[28]

10.4161/derm.21923

[29]

10.1111/dth.14881

[30]

10.5021/ad.2014.26.3.401

[31]

Yew CH "Response to intradermal autologous platelet rich plasma injection in refractory dermal melasma: report of two cases" JUMMEC (2015)

[32]

10.1080/09546634.2018.1524821

[33]

10.1111/jocd.13157

[34]

10.1080/09546634.2020.1781755

Cited By

23

Efficacy of Microneedle Fractional Radiofrequency Combined With Platelet‐Rich Plasma for the Treatment of Melasma: A Split‐Face, Randomized Trial

Ziyan Chen, Yuhao Li · 2026

Journal of Cosmetic Dermatology

Metrics

23

Citations

34

References

Details

Published: Jun 03, 2021
Vol/Issue: 20(8)
Pages: 2431-2436
License: View

Authors

A

Ankita Tuknayat

Department of Dermatology Government Medical College and Hospital Chandigarh India

M

Mala Bhalla

Department of Dermatology Government Medical College and Hospital Chandigarh India

G

Gurvinder Pal Thami

Department of Dermatology Government Medical College and Hospital Chandigarh India

Cite This Article

Ankita Tuknayat, Mala Bhalla, Gurvinder Pal Thami (2021). Platelet‐rich plasma is a promising therapy for melasma. Journal of Cosmetic Dermatology, 20(8), 2431-2436. https://doi.org/10.1111/jocd.14229

Platelet‐rich plasma is a promising therapy for melasma

You May Also Like